Literature DB >> 18946618

Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.

S P Singh1, S C Gupta.   

Abstract

INTRODUCTION: This study was performed with the objective of determining the efficacy of naked eye single tube red cell osmotic fragility test (NESTROFT) as a screening test for beta-thalassaemia trait, and to standardise a saline concentration which could give best results with minimum error and maximum sensitivity and specificity.
METHODS: Five concentrations (0.35 percent, 0.36 percent, 0.37 percent, 0.38 percent and 0.39 percent) of buffered saline solutions were used. NESTROFT was applied to three groups of subjects: 24 normal individuals, 87 subjects with genetically-proven beta-thalassaemia trait and 13 patients with proven iron-deficiency anaemia.
RESULTS: The results demonstrated that 0.36 percent was the best saline concentration for NESTROFT. It could detect 97.7 percent of heterozygous beta-thalassaemia patients, compared to 94.25 percent, 91.95 percent, 88.51 percent and 82.76 percent detection rates obtained with 0.35 percent, 0.37 percent, 0.38 percent and 0.39 percent saline concentrations, respectively. Specificity of NESTROFT with 0.36 percent saline was also higher at 83.3 percent, whereas that of 0.35 percent, 0.37 percent, 0.38 percent and 0.39 percent was 79.17 percent, 79.17 percent, 70.83 percent and 62.5 percent, respectively. This test with 0.36 percent saline concentration was also positive for three (23.08 percent) patients with iron-deficiency anaemia.
CONCLUSION: NESTROFT done with 0.36 percent buffered saline solution provides more accurate results compared to the other concentrations tested. Since the test is sensitive, cost-effective, rapid and reliable, it may be considered as the single screening test to be used in areas with limited laboratory facilities and economic resources.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946618

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

Review 1.  Abnormal haemoglobins: detection & characterization.

Authors:  Henri Wajcman; Kamran Moradkhani
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

2.  Economic Burden of Thalassemia Major in Iran, 2015.

Authors:  Firooz Esmaeilzadeh; Azita Azarkeivan; Sara Emamgholipour; Ali Akbari Sari; Mehdi Yaseri; Batoul Ahmadi; Mohtasham Ghaffari
Journal:  J Res Health Sci       Date:  2016

3.  NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.

Authors:  Manasi Gosavi; Ramesh Chavan; M B Bellad
Journal:  J Lab Physicians       Date:  2021-07-09

4.  EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.

Authors:  Joanne Traeger-Synodinos; Cornelis L Harteveld; John M Old; Mary Petrou; Renzo Galanello; Piero Giordano; Michael Angastioniotis; Barbara De la Salle; Shirley Henderson; Alison May
Journal:  Eur J Hum Genet       Date:  2014-07-23       Impact factor: 4.246

5.  Hemolysis area: A new parameter of erythrocyte osmotic fragility for screening of thalassemia trait.

Authors:  Thanusak Tatu; Denis Sweatman
Journal:  J Lab Physicians       Date:  2018 Apr-Jun

6.  Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review.

Authors:  Amani Abu-Shaheen; Humariya Heena; Abdullah Nofal; Doaa A Abdelmoety; Abdulrahman Almatary; Mohammed Alsheef; Isamme AlFayyad
Journal:  Biomed Res Int       Date:  2020-10-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.